Religare Enterprises (REL) reported FY26 consolidated revenue of ₹8,494 Cr.

Its health insurance arm, Care Health, a top standalone insurer, saw Gross Written Premium jump 24% YoY to ₹11,417 Cr and profit before tax (PBT) rise 38% to ₹539 Cr.

Religare Finvest (NBFC) posted a strong PAT of ₹138.8 Cr for FY26, now debt-free with a robust 261.9% capital adequacy ratio (CRAR). Religare Broking recorded stable income at ₹373 Cr.

Key strategic moves include a ₹1,500 Cr capital raise via preferential issue and the demerger of financial services for sharper focus.

The Burman Group is now the designated promoter, boosting its stake to ~30.3% and contributing ₹750 Cr.

Recent developments saw the RBI lift all restrictions on Religare Finvest, resolving legacy issues.

Management is focused on accelerating growth in Care Health through customer-centric products and tech innovation.

RFL aims to expand SME lending from a clean slate.

Overall, the group is strengthening governance and capital to drive scalable, sustainable growth across its key platforms.